Session handouts and meetings archive

Handouts ... 2025 Innovation Academy, Chicago, IL, July 10-13 2025 Annual Meeting, Orlando, FL, March 7-11 2024 Innovation Academy, Seattle, WA, August 1-4 2024 Annual Meeting, San Diego, CA, March 8-12 2023 Innovation Academy, Tampa, FL, August 10-13 2023 Annual Meeting, New Orleans, LA, March 17-21 Sessions ... 2025 Innovation

CME & session evaluation archive

Claim CME & submit session evaluations ... Claim CME credit and submit session evaluations for attending previous Academy meetings: ... 2025 Innovation Academy, Chicago, IL, July 10-13 2025 Annual Meeting, Orlando, FL, March 7-11 2024 Innovation Academy, Seattle, WA, August 1-4 2024 Annual Meeting, San Diego, CA, March 8-12 2023

AADA hosts largest Capitol Hill skin cancer check in a decade

On May 15, the AADA hosted its 10th annual Capitol Hill Skin Cancer Check and Health Fair with the Congressional Skin Cancer Caucus. This event was our largest to date, hosting 198 Hill staffers and 11 members of Congress, performing 127 skin checks, and providing 75 Reveal camera image results.

PDF of AADA support letter

Honorable Lisa Murkowski The Honorable Tom Udall Chairman Ranking Member Subcommittee on Interior

IA25 Meeting Suites Guidelines

charge to be billed directly through Freeman: • exterior graphic panel to the right of the door • Interior

2025 AAD Annual Meeting | Exhibitor Meeting Suites Guidelines

to be billed directly through Freeman: • (1) exterior graphic panel to the right of the door • Interior

2026 AAD Annual Meeting | Exhibitor Meeting Suites Guidelines

to be billed directly through Freeman: • (1) Exterior graphic panel to the right of the door • Interior

Biotin supplementation for hair and nail health: Does it pass the test?

By Warren R. Heymann, MD, FAAD November 17, 2021 Vol. 3, No. 46 When patients ask me about biotin supplementation for their hair or nails, the usual question is what dose they should take, not whether or not it has any value. High dose over-the-counter biotin supplements (≥ 5 mg/day,

AAD Event Advertising: Annual Meeting

The Academy's Annual scientific meeting offers unprecedented access to thousands of dermatologists attending high-profile continuing medical education events. ... For exhibitors looking to promote their products and services, build booth traffic, and facilitate face-to-face discussions, the Academy offers a wide selection of high-impact advertising opportunities. Look here for advertising opportunities

Key messages to communicate about Indoor tanning

Key messages ... Using indoor tanning beds can increase your risk of skin cancer, including melanoma, the deadliest form of skin cancer. (1-15) ... Using tanning beds before age 20 can increase your chances of developing melanoma by 47%, and the risk increases with each use. (16) ... Women younger

Dermatologists warn people about the reliability of online symptom checkers

Research shows that online symptom checkers inaccurately diagnose skin rashes ROSEMONT, Ill. (October 12, 2022) — Thanks to the internet, we have the world at our fingertips, and with just a few clicks, we can easily enter our medical symptoms into websites and apps to self-diagnose illnesses. However, a new

PDF of Nominating Committee Member Rep. Regional Map

the PE WEST REGION OF THE UNITED STATES QC ON AND CANADIAN PROVINCES ONLY NS (Shown in Pink) ND WA

PDF of Board of Directors Regional Map

NL 9 BC 40 NL AB SK MB 9 47 4 12 PE QC 1 ON 64 NS 140 20 WA ND MT NB 333 46 22

Academy physician leaders meet with federal legislators

On June 4, AADA physician leaders met with legislators in Washington, D.C., as part of the House Call on the Mall fundraiser hosted by the National Republican Congressional Committee and Rep. John Joyce, MD, FAAD (R-PA). During the event, AADA leaders reiterated the importance of Medicare physician payment reform. ...

2025 AAD Innovation Academy Attendee Statistics

Innovation Academy Attendance over the years: 2024 – Seattle, WA ..................................

AADA hosts 10th annual Capitol Hill Skin Cancer Check and Health Fair

Moving the needle ... By Apoorva Stull, Senior Manager, Advocacy Communications, May 1, 2024 DermWorld ... breaks down the latest highlights of AADA advocacy activities at the federal and state legislative and regulatory level. On May 15, the AADA hosted its 10th annual Capitol Hill Skin Cancer Check and Health

PDT for erosive pustular dermatitis of the scalp: Seeing the light (but reaching a different conclusion)

By Warren R. Heymann, MD June 9, 2016 Erosive Pustular Dermatitis of the Scalp (EPDS) is a relative common condition, typically seen on the actinically damaged scalps of the elderly men. Lesions characteristically present as hyperkeratotic, crusted erosions with varying degrees of pustulation. Lesions may become secondarily infected. The etiology

2024 AAD Innovation Academy | Official exhibitor suppliers

Experient) is the official housing provider for the 2024 AAD Innovation Academy Meeting in Seattle, WA

Medical research funding

Ask the Expert ... By Victoria Houghton, managing editor, August 1, 2021 DermWorld ... spoke to Jennifer Mangone, JD, manager of congressional policy for the American Academy of Dermatology Association (AADA), about the Academy’s advocacy efforts to support medical research funding. DermWorld: Advocating for medical research funding is a top

Getting down to brass tacks

Go to AAD Home ... Go to AAD Home ... Menu ... Dermatology World unlocks the basics of physician entrepreneurship ... Dermatology World unlocks the basics of physician entrepreneurship ... By Ruth Carol, contributing writer Inspired by your entrepreneurial colleagues who were featured in the August issue of ... Dermatology

Becoming pro-geriatric by understanding progeria

By Warren R. Heymann, MD Aug. 13, 2018 A fifteen-year-old boy with Hutchinson-Gilford progeria syndrome. ... Credit: ... JAAD I have never seen a case of Hutchinson-Gilford progeria syndrome (HGPS). You probably haven’t either, given its incidence of 1 in 4 million. Why comment on a disease that will likely

The ironclad promise of ferroptosis

By Warren R. Heymann, MD, FAAD Jan. 25, 2023 Vol. 5, No. 4 As checkpoint inhibition of programmed cell death protein 1 (PD1) has become standard oncologic therapy, it is easy to forget that this revolutionary therapy is barely a decade old. Until 1972, cell death was considered passive and

The pachydermoperiostosis prostaglandin paradigm

By Warren R. Heymann, MD July 10, 2019 Vol. 1, No. 18 Prostaglandins were the rage when I started medical school in 1975; their role in inflammatory dermatoses was considered of paramount importance throughout my residency in the early 1980s. Hours were spent studying the transformation of arachidoinic acid to

PDF of BF transplant dermatology

Am J Transplant. 2017 Nov;17(11):2782-2789. doi: 10.1111/ajt.14337. Epub 2017 May 30.

Advocacy Update Feb. 4 2025

IN THIS ISSUE / Feb. 4, 2025 Physician champions introduce Medicare physician payment fix in House Academy joins coalition urging less regulatory burdens in Medicare Advantage and Part D program AADA urges CMS to improve MVP framework Become an AADA Advocacy Key Contact Support dermatology champions in Congress through SkinPAC

Advocacy Update Dec 9, 2025

IN THIS ISSUE / Dec. 9, 2025 AADA endorses annual inflationary update to Medicare payment legislation Upcoming formulary prior authorization changes to Blue Cross Blue Shield’s federal employee coverage Podcast highlights advocacy on dermatopathology payer and regulatory challenges AMA offering $1 million in community health program grants Peter Friedman, MD,

Taking the challenge: Social media, adolescents, and the skin

By Albert C. Yan, MD June 12, 2019 Vol. 1, No. 14 Patterned skin injury can raise the specter of non-accidental trauma. However, over the past decade or so, striking examples of patterned skin injury have emerged among adolescents and pre-teens that share certain features: these are self-induced voluntarily; the

PS-Joint Position Statement on Buffered Lidocaine

If a PEC is used, all interior surfaces of the PEC should be cleaned and disinfected at the beginning

Advocacy Update Feb. 18 2025

IN THIS ISSUE / Feb. 18, 2025 AADA, house of medicine demand reversal of Medicare cut and provide a pay boost AADA highlights need for Medicare physician payment reform at House Committee on Ways and Means hearing Dermatology addresses new CLIA requirements for lab directors Legislators reject pharmacists’ effort to

Advocacy Update Mar. 18, 2025

IN THIS ISSUE / Mar. 18, 2025 AADA outraged that Congress passed government funding without doc fix AADA advocates for dermatologists in CLIA lab director requirements FDA testing confirms minimal benzene in most benzoyl peroxide acne products, some voluntary recalls issued Add your voice and become an AADA Advocacy Key

Propranolol and neutrophilic dermatoses: Can beta-blockade be better blockade?

By Warren R. Heymann, MD, FAAD December 8, 2021 Vol. 3, No. 48 Ask any dermatology resident what the first-line treatment is for infantile hemangiomas (IH) and you will get a matter-of-fact response — "propranolol" — as if this has been an entrenched fact for decades. Barely more than a

Lipoid proteinosis’ weak, hoarse cry is crying for targeted therapeutic intervention

By Warren R. Heymann, MD, FAAD Nov. 6, 2024 Vol. 6, No. 45 Having recently participated in the excellent conference devoted to antisemitism in medicine organized by Heather Milbar at the University of Pennsylvania, I reacquainted myself with Erich Urbach, who described lipoid proteinosis (LP, Urbach-Wiethe disease) with the otolaryngologist

Of strife and SDRIFE

By Warren R. Heymann, MD May 17, 2017 Patient 3. SDRIFE. Frontal view (A) and right lateral view (B) with erythema and blanching papules coalescing into plaques with vesicles on back, abdomen, and bilateral inframammary and inguinal folds. ... Credit: ... JAAD A conceivable Yelp review: I was so uncomfortable

Surviving and thriving after a natural disaster

Answers in Practice ... By Emily Margosian, Assistant Editor, September 1, 2023 DermWorld ... talks to Mary Lupo, MD, FAAD, from the Lupo Center for Aesthetic and General Dermatology in New Orleans, about how to prepare your practice for a natural disaster. Mary Lupo, MD, FAAD ... DermWorld: Tell us

Unrestricted fascination with restrictive dermopathy

By Warren R. Heymann, MD, FAAD Nov. 16, 2022 Vol. 4, No. 46 Barely a week into our fellowships at the University of Pennsylvania in 1984, my wife (a geneticist) asked her favorite dermatologist (me) if I had any thoughts about a neonate with skin that was thin, taut, and

Propranolol for infantile hemangiomas: Start to finish

By Warren R. Heymann, MD, FAAD March 26, 2025 Vol. 7, No. 12 "We have observed that propranolol can inhibit the growth of these [infantile capillary] hemangiomas." (1) In my career, I cannot think of any statement that led to such a swift, dramatic paradigm shift in management more than

Untangling the neurologic comorbidities of bullous pemphigoid

By Warren R. Heymann, MD June 6, 2017 Response of a patient with bullous pemphigoid (BP) after 6 omalizumab injections as monotherapy. A, Involvement of the back of a steroid-refractory patient with BP before omalizumab treatment. B, Four months after beginning omalizumab as monotherapy, the inflammatory plaques have largely resolved,

PDF of Histiocytosis

Kornik RI, Naik HB, Lee CC, Estrada-Veras J, Gahl WA, Cowen EW.

Glucose monitors: Not as sweet as they seem

By Christen M. Mowad, MD Oct. 9, 2019 Vol. 1, No. 31 ... The next contact allergen of the year has been announced early by the American Contact Dermatitis Society and it is an acrylate, isobornyl acrylate. (1) This chemical is a photopolymerizable monomer that has been used in industrial

Clinical pearls: DRESS syndrome

W., Yang, M. S., of DRESS and the culprit drugs are sulfas, carbamaze- Kim, S. H., Kang, H.

Researching therapeutic reformation of the capillary malformation: Arteriovenous Malformation Syndrome

By Warren R. Heymann, MD June 17, 2020 Vol. 2, No. 24 Small cutaneous lesions may have profound systemic implications. Astute dermatologists will recognize these lesions and assess patients accordingly, often to the surprise of referring physicians and patients alike. ... The Capillary Malformation – Arteriovenous Malformation (CM-AVM) syndrome was

Going green: The complexities of the green nail syndrome

By Warren R. Heymann, MD February 3, 2021 Vol. 3, No. 5 I find a unique satisfaction in diagnosing the green nail syndrome (GNS, aka chloronychia, Goldman-Fox syndrome) — it is easy to recognize and very reassuring to patients who were convinced they had a subungual melanoma. Based on new

2020 Legislative Conference Overview of Asks

Suzan DelBene, D-WA, Mike Kelly, R-PA, Ami Bera, MD, D-CA, and Roger Marshall, MD, R-KS.

Terra Firma-Forme Dermatosis

By Warren R. Heymann, MD, FAAD Nov. 13, 2024 Vol. 6, No. 46 The renowned gastroenterologist was rounding with his fellows when he summoned me to his patient’s bedside to impress me with his astute diagnosis of malignant acanthosis nigricans, having admitted his patient for an extensive endoscopic work-up for

Not aging like fine wine: The myths and mysteries of acquired port wine stains

By Warren R. Heymann, MD January 13, 2021 Vol. 3, No. 2 Port wine stains (PWS, aka nevus flammeus, nevus simplex, salmon patch) are cutaneous capillary malformations that are characteristically congenital (CPWS) but may be acquired (APWS). APWS was first described in a German publication by Fegeler in 1949, hence

Beef tallow for eczema: Grade A prime or just another bum steer?

By Andrew C. Krakowski, MD, FAAD June 18, 2025 Vol. 7, No. 24 As a pediatric dermatologist, I have seen skin care trends come and go faster than a cow fleeing a branding iron. Lately, social media — especially herd-mentality platforms like TikTok — has been bullish on beef tallow

Keeping an eye on melanoma

By Warren R. Heymann, MD April 7, 2021 Vol. 3, No. 14 If your practice bears any resemblance to mine, a significant portion of your schedule is devoted to patients following up because of their history of melanoma. Prior to seeing the patient, our medical assistant runs through a focused

Indoor tanning fact sheet

Indoor tanning use ... The global prevalence of indoor tanning in adolescents for 2013-2018 was 6.5%, and 10.4% in adults. (1) ... Though the numbers have been decreasing in recent years, approximately 7.8 million adults in the U.S. still engage in indoor tanning. (2,3) ... Among high school students in

PDF of Academy interim guidance on the use of biologics during the COVID-19 pandemic.

Yang J, Zheng Y, Gou X, et al.

Paradoxical biological reactions and Grandma Dora’s waterbed

By Warren R. Heymann, MD January 22, 2020 Vol. 2, No. 3 My late maternal grandmother Dora — a real ... balabusta (Yiddish for "mistress of the house") — was the first person I knew to get a waterbed. That raised eyebrows, until I explained that it comforted her octogenarian

2024 AAD Annual Meeting Sponsorship Prospectus

sponsorships are also available for the 2024 AAD Innovation Academy (formerly Summer Meeting) in Seattle, WA

Tofacitinib: A JAK inhibitor of all trades

By Warren R. Heymann, MD April 3, 2019 Vol. 1, No. 4 The Janus kinase inhibitors are taking the dermatologic therapeutic world by storm — at least in the literature. By now, most dermatologists are familiar with studies that have demonstrated efficacy in alopecia areata, vitiligo, psoriasis, psoriatic arthritis, and

Playing the field: Introducing tirbanibulin for actinic keratosis therapy

By Warren R. Heymann, MD January 27, 2021 Vol. 3, No. 4 Field therapy is a cornerstone of actinic keratosis (AK) management. Two years ago, a ... New England Journal of Medicine article demonstrated that 5-fluorouracil (5-FU) was the best among inadequate therapies (compared to imiquimod, MAL-PDT, and ingenol mebutate).

Netherton syndrome: From apex to nether

By Warren R. Heymann, MD March 31, 2021 Vol. 3, No. 13 If you are a dermatologist preparing for your board exam, I’ll wager that you can rattle off the classical features of Netherton syndrome (NS, aka Comel-Netherton syndrome) in a heartbeat. The more important question — would you recognize

Cannabis arteritis: Getting higher on the differential diagnosis list of ulcerative lesions

DermWorld Insights and Inquiries ... By Warren R. Heymann, MD, FAAD, January 1, 2026 Vol. 8, No. 1 Marijuana use is on the rise. In 2022, nearly 22% of people had used the drug in the past year, with steep increases in the number of people 65 and older who

Homing in on hornerin: Breaking down the barrier to understand its crucial role in atopic dermatitis

By Warren R. Heymann, MD, FAAD Oct. 16, 2024 Vol. 6, No. 42 Atopic dermatitis (AD) is characterized by skin barrier dysfunction, inflammation, and chronic pruritus. The etiology of AD, however, is complicated and incompletely understood, with genetic, environmental (soaps, surfactants, stress), and immunological factors causing skin barrier abnormalities and

Topical tacrolimus topics

By Warren R. Heymann, MD August 26, 2020 Vol. 2, No. 34 What were you doing in 2000? Worrying about counting chads in Florida? If you were a dermatologist, you were probably eagerly awaiting the release of topical tacrolimus (Protopic) and pimecrolimus (Elidel) two years later. These topical calcineurin inhibitors

Can topical ketoconazole tip the scales for acne vulgaris?

By Warren R. Heymann, MD Oct. 28, 2020 Vol. 2, No. 43 How often do you perform an oral examination? If you’re like me, probably only under two circumstances — when the patient has specific complaints (soreness, a raised lesion, or a discoloration noted by their dentist), or when we

Sparking the interest in Spark nevus

By Jason B. Lee, MD, FAAD Dec. 13, 2023 Vol. 5, No. 49 The late A. Bernard Ackerman has described and named a variety of dermatologic entities, expanding the lexicon of dermatology over his career. He has been known to come up with catchy and playful names for dermatologic entities

JAK inhibitors battle in the heavyweight class

By Warren R. Heymann, MD, FAAD Nov. 12, 2025 Vol. 7, No. 45 Editor’s Note: A modified version of this commentary appeared as "A Clinician’s Perspective" in JAAD ... . JAK inhibitors (JAKi) have catapulted to such prominence in dermatologic therapeutics that I could write a weekly commentary about them.

PDF of AAD Atopic Dermatitis pediatric comorbid conditions guideline draft

Chiu CY, Yang CH, Su KW, Tsai MH, Hua MC, Liao SL et al.

After 23 years, a syndrome converted me into an eflornithine believer

By Warren R. Heymann, MD, FAAD July 12, 2023 Vol. 5, No. 28 I learned that Vaniqa (eflornithine - ... α -difluoromethylornithine [DFMO]) was discontinued. Topical eflornithine was released in 2000 to reduce facial hirsutism. When the drug was released, I recall being fascinated by the premise of its mechanism.

Hemochromatosis: Beyond 50 shades of gray

By Warren R. Heymann, MD, FAAD March 6, 2024 Vol. 6, No. 10 As a medical student, I was enamored by the term "bronze diabetes" as a depiction of hemochromatosis; ever since I have been magnetically attracted to the disease. Hereditary (primary) hemochromatosis is a common autosomal-recessive disorder, with a

Incysting on understanding pilar cysts

By Warren R. Heymann, MD July 15, 2020 Vol. 2, No. 28 Chances are you will see patients with at least one pilar cyst today. You will reassure them of their benignity, stating that the risk of their becoming cancerous is infinitesimal, and perhaps you will excise some lesions. Inquisitive

The breathless complications of anti-MDA-5-positive dermatomyositis

By Warren R. Heymann, MD, FAAD Oct. 30, 2024 Vol. 6, No. 44 Dermatologists are familiar with the spectrum of dermatomyositis (DM) — classic DM, juvenile DM, amyopathic DM, and cancer-associated DM. Clinically, amyopathic DM is a form in which the patients typically develop characteristic cutaneous features of DM [heliotrope

March 20, 2023 AAD/A Board of Directors agenda

Resort & Spa, Itasca, IL 2024 Innovation Academy – August 1-4, 2024 (Thurs – Sun) Seattle, WA

Agenda of the July 23, 2022 AAD/A Board of Directors meeting.

600 PM – 9:00 PM (Central) 2024 Innovation Academy Meeting – Seattle, WA

Promising therapeutic developments for cutaneous lupus erythematosus: Interfering with interferon

By Warren R. Heymann, MD, FAAD Aug. 17, 2022 Vol. 4, No. 33 Disfigurement due to scars and dyspigmentation complicating discoid lupus erythematosus (DLE) can be devastating. The cornerstones of therapy for cutaneous lupus erythematosus (CLE) are steroids (topical, intralesional, systemic) and antimalarials (hydroxychloroquine, chloroquine, quinacrine). Secondary agents include immunosuppressive

The nexus of VEXAS syndrome

By Warren R. Heymann, MD, FAAD December 1, 2021 Vol. 3, No. 47 You may not be familiar with VEXAS (Vacuoles, E1 enzyme, X-linked, Autoinflammatory, Somatic) syndrome, but it is conceivable that you have already unknowingly encountered patients with the disorder. ... To appreciate the clinical nuances of the VEXAS

The vexing verruciform xanthoma

By Warren R. Heymann, MD, FAAD February 23, 2022 Vol. 4, No. 8 Verruciform xanthomas (VX) were first described 50 years ago, and they are still a source of debate. Only the most astute dermatologists will make the diagnosis clinically, with the possible exception of recognizing such lesions in patients

Striving to avoid an amebic nightmare: Recognizing cutaneous Balamuthia mandrillaris infection

By Warren R. Heymann, MD, FAAD May 22, 2024 Vol. 6, No. 21 Having received the worry gene from my mother, I have nightmares about missing diagnoses that have potentially devastating outcomes. My anxiety level reached new heights over 20 years ago, listening to a presentation by Dr. Amit Pandya

AAD Innovation Academy 2020 Technical Exhibitor Prospectus

Friday. 70 Pike St., Seattle, WA 98101 Welcome Reception (Exhibits Open) 3 Thursday, August 13 ......

Giving a NOD2 to Yao syndrome

By Warren R. Heymann, MD, FAAD March 5, 2025 Vol. 7, No. 9 The 21 ... st ... century has witnessed an expanding array of systemic autoinflammatory disorders (SAIDs) due to innate immunity dysfunction. SAIDs are characterized by recurrent attacks of fever, cutaneous signs, chest or abdominal pain, lymphadenopathy, vasculopathy,

Agenda for the Nov. 5, 2022 meeting of the AAD and AADA Board of Directors meetings.

6:00 PM – 9:00 PM (Central) 2024 Innovation Academy Meeting – Seattle, WA

Deeper thoughts about acne keloidalis nuchae

DermWorld Insights and Inquiries ... By Warren R. Heymann, MD, FAAD, February 1, 2026 Vol. 8, No. 2 Wallace Clark taught me the truism that thinking often ceases when a diagnosis is rendered. The clinical diagnosis of acne keloidalis nuchae (AKN) is straightforward. Embarrassingly, I had not given much thought

Metformin mania: Is it an adequate chemopreventive agent for skin cancer?

By Warren R. Heymann, MD, FAAD Aug. 31, 2022 Vol. 4, No. 35 Precisely a century ago (in 1922) metformin was synthesized, based on the folk knowledge that the active, but toxic constituent guanidine galegine, (derived from French lilac, ... Galega officinalis ) could treat "sweet urine." Metformin is now

Treatments for renal IgA vasculitis are beginning to flow

By Warren R. Heymann, MD, FAAD Feb. 19, 2025 Vol. 7, No. 7 The alliterative phrase "palpable purpura" will instantly conjure the diagnosis of leukocytoclastic vasculitis (LCV) for dermatologists. IgA vasculitis (IgAV, aka Henoch-Schönlein purpura [HSP]) is the most common vasculitis in children but is much less frequent in adults.

PDF of AAD Atopic Dermatitis diagnostic testing supplement draft

Li Y, Yang X, Lu J, Chen K, Wu W, Zhang M , Li W.

Exchanging plasma exchange for a novel approach: The potential of FcRn antagonists in dermatologic autoimmune disease

By Warren R. Heymann, MD, FAAD Nov. 1, 2023 Vol. 5, No. 44 Pemphigus vulgaris (PV) and pemphigus foliaceus (PF) are potentially life-threatening disorders demanding aggressive therapy with all the finesse and skill that dermatologists can muster. PV is characterized by IgG autoantibodies targeting desmoglein (Dsg)‐3, which is associated with

The profound dermatological manifestations of COVID-19

By Warren R. Heymann, MD March 18, 2020 Vol. 2, No. 11 Disclaimers: This commentary was written on March 12, 2020 for a publication date of March 18, 2020. The issues related to the COVID-19 pandemic are changing at breakneck speed. The content included in this commentary may no longer

The appropriate dermatologic response when considering the capillary malformation-arteriovenous malformation syndrome: Fast flow to referral

By Warren R. Heymann, MD, FAAD Sept. 18, 2024 Vol. 6, No. 38 I have had the privilege of contributing to Dr. Ronni Wolf’s outstanding AAD symposium devoted to Emergency Dermatology by presenting the lecture "Dermatological Urgent Care: When Banalities Surprise You," discussing several cutaneous disorders that could easily be

A medal-worthy diagnosis: Medallion-like dermal dendrocyte hamartoma

By Warren R. Heymann, MD, FAAD Aug. 30, 2023 Vol. 5, No. 35 A personal joy of dermatology is rendering a diagnosis in a lesion or rash that I have only read about but never previously encountered in practice. Beyond being intellectually satisfying, having a precise diagnosis is reassuring, as

PDF of the supplement to the draft atopic dermatitis comorbidities guideline

Kijima A, Murota H, Takahashi A, Arase N, Yang L, Nishioka M et al.

PDF of AAD Atopic Dermatitis pediatric comorbid conditions supplement draft

Chiu CY, Yang CH, Su KW, Tsai MH, Hua MC, Liao SL et al.

AAD guidance on steps members can take in response to COVID-19

Yang J, Zheng Y, Gou X, et al.

PDF of proposed guidelines on AD and phototherapy

Tzung TY, Lin CB, Chen YH , Yang CY.

PDF of draft atopic dermatitis comorbidities guideline

Kijima A, Murota H, Takahashi A, Arase N, Yang L, Nishioka M et al.

Directions in Residency, Summer 2023, PDF

W., Yang, M. S., of DRESS and the culprit drugs are sulfas, carbamaze- Kim, S. H., Kang, H.

PDF of AAD Atopic Dermatitis diagnostic testing guideline draft

Tian J, Zhang D, Yang Y, Huang Y, Wang L, Yao X , Lu Q.

PDF of member ethics resources

Yang CS, Kroumpouzos G, Bercovitch L.

Professionalism and Ethics

Ethics and medicine have been intertwined since the dawn of our profession. From the ancient Hippocratic Oath to the principle of ... primum non nocere to modern-day principlism, medical ethics have evolved over time. ... As public and professional interest in medical ethics increases, it is important for clinicians, researchers,

Search

Filters

Content Filters

Content Type